Status
Conditions
About
Mutation-positive peripheral blood ctDNA became mutation-negative after surgical removal of the cancer tissue. All subjects in the control group were negative for ctDNA mutations。
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:Patients with pulmonary nodules who underwent curative-intent resection were able to enter the study -
Exclusion Criteria:Patients who received any invasive examination or treatment prior to resection or had a history of malignancy; patients who do not attend follow up after surgery; blood samples that were contaminated; and biopsies that exhibited advanced lung cancer in pathology。
Loading...
Central trial contact
Mengqin Xu, Master; Jianping chief physician, Doctor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal